These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32660869)

  • 1. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X Syndrome.
    Berry-Kravis E; Horrigan JP; Tartaglia N; Hagerman R; Kolevzon A; Erickson CA; Hatti S; Snape M; Yaroshinsky A; Stoms G; ; Glass L; Jones NE
    Pediatr Neurol; 2020 Sep; 110():30-41. PubMed ID: 32660869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome.
    Glaze DG; Neul JL; Percy A; Feyma T; Beisang A; Yaroshinsky A; Stoms G; Zuchero D; Horrigan J; Glass L; Jones NE
    Pediatr Neurol; 2017 Nov; 76():37-46. PubMed ID: 28964591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.
    Glaze DG; Neul JL; Kaufmann WE; Berry-Kravis E; Condon S; Stoms G; Oosterholt S; Della Pasqua O; Glass L; Jones NE; Percy AK;
    Neurology; 2019 Apr; 92(16):e1912-e1925. PubMed ID: 30918097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Peters SU; Jones NE; Youakim JM
    Contemp Clin Trials; 2022 Mar; 114():106704. PubMed ID: 35149233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Marsh ED; Lin T; Stankovic S; Bishop KM; Youakim JM
    Nat Med; 2023 Jun; 29(6):1468-1475. PubMed ID: 37291210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure-Response Efficacy Modeling to Support Trofinetide Dosing in Individuals with Rett Syndrome.
    Darwish M; Passarell J; Youakim JM; Bradley H; Bishop KM
    Adv Ther; 2024 Apr; 41(4):1462-1480. PubMed ID: 38363467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.
    Berry-Kravis EM; Harnett MD; Reines SA; Reese MA; Ethridge LE; Outterson AH; Michalak C; Furman J; Gurney ME
    Nat Med; 2021 May; 27(5):862-870. PubMed ID: 33927413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.
    Youssef EA; Berry-Kravis E; Czech C; Hagerman RJ; Hessl D; Wong CY; Rabbia M; Deptula D; John A; Kinch R; Drewitt P; Lindemann L; Marcinowski M; Langland R; Horn C; Fontoura P; Santarelli L; Quiroz JA;
    Neuropsychopharmacology; 2018 Feb; 43(3):503-512. PubMed ID: 28816242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of trofinetide in Rett syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Abbas A; Fayoud AM; El Din Moawad MH; Hamad AA; Hamouda H; Fouad EA
    BMC Pediatr; 2024 Mar; 24(1):206. PubMed ID: 38521908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
    Berry-Kravis E; Des Portes V; Hagerman R; Jacquemont S; Charles P; Visootsak J; Brinkman M; Rerat K; Koumaras B; Zhu L; Barth GM; Jaecklin T; Apostol G; von Raison F
    Sci Transl Med; 2016 Jan; 8(321):321ra5. PubMed ID: 26764156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome.
    Neul JL; Percy AK; Benke TA; Berry-Kravis EM; Glaze DG; Peters SU; Marsh ED; An D; Bishop KM; Youakim JM
    Pediatr Neurol; 2024 Mar; 152():63-72. PubMed ID: 38232652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome.
    Leigh MJ; Nguyen DV; Mu Y; Winarni TI; Schneider A; Chechi T; Polussa J; Doucet P; Tassone F; Rivera SM; Hessl D; Hagerman RJ
    J Dev Behav Pediatr; 2013 Apr; 34(3):147-55. PubMed ID: 23572165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
    Berry-Kravis EM; Hessl D; Rathmell B; Zarevics P; Cherubini M; Walton-Bowen K; Mu Y; Nguyen DV; Gonzalez-Heydrich J; Wang PP; Carpenter RL; Bear MF; Hagerman RJ
    Sci Transl Med; 2012 Sep; 4(152):152ra127. PubMed ID: 22993294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of donepezil in boys with fragile x syndrome: a double-blind, randomized, controlled pilot study.
    Sahu JK; Gulati S; Sapra S; Arya R; Chauhan S; Chowdhury MR; Gupta N; Kabra M; Gupta YK; Dwivedi SN; Kalra V
    J Child Neurol; 2013 May; 28(5):570-5. PubMed ID: 22752489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of the efficacy and safety of trofinetide in patients with rett syndrome.
    Abo Zeid M; Elrosasy A; Mohamed RG; Ghazou A; Goufa E; Hassan N; Abuzaid Y
    Neurol Sci; 2024 May; ():. PubMed ID: 38771525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives.
    Moore R; Poulsen J; Reardon L; Samples-Morris C; Simmons H; Ramsey KM; Whatley ML; Lane JB
    Adv Ther; 2024 Apr; 41(4):1305-1317. PubMed ID: 38378975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.
    Berry-Kravis E; Krause SE; Block SS; Guter S; Wuu J; Leurgans S; Decle P; Potanos K; Cook E; Salt J; Maino D; Weinberg D; Lara R; Jardini T; Cogswell J; Johnson SA; Hagerman R
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):525-40. PubMed ID: 17069542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.